These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9313926)

  • 21. Ibuprofen or ozagrel increases NO release and l-nitro arginine induces TXA(2) release from cultured porcine basilar arterial endothelial cells.
    Miyamoto A; Hashiguchi Y; Obi T; Ishiguro S; Nishio A
    Vascul Pharmacol; 2007 Feb; 46(2):85-90. PubMed ID: 17113355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium.
    Seeger W; Bauer M; Bhakdi S
    J Clin Invest; 1984 Sep; 74(3):849-58. PubMed ID: 6432850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac release of prostacyclin and thromboxane A2 during coronary revascularization.
    Teoh KH; Fremes SE; Weisel RD; Christakis GT; Teasdale SJ; Madonik MM; Ivanov J; Mee AV; Wong PY
    J Thorac Cardiovasc Surg; 1987 Jan; 93(1):120-6. PubMed ID: 3540456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelin-1 releases endothelium-derived endoperoxides and thromboxane A2 in porcine coronary arteries with regenerated endothelium.
    Park SJ; Lee JJ; Vanhoutte PM
    Zhongguo Yao Li Xue Bao; 1999 Oct; 20(10):872-8. PubMed ID: 11270983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methacholine-induced contraction of rabbit pulmonary artery: role of platelet-endothelial transcellular thromboxane synthesis.
    Pfister SL; Deinhart DD; Campbell WB
    Hypertension; 1998 Jan; 31(1 Pt 2):206-12. PubMed ID: 9453304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
    Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
    Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of endothelial cyclo-oxygenase metabolites in noradrenaline-induced contraction of rat coronary artery.
    Wang A; Nishihashi T; Trandafir CC; Murakami S; Ji X; Shimizu Y; Kurahashi K
    Clin Exp Pharmacol Physiol; 2005 Aug; 32(8):628-32. PubMed ID: 16120189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of endothelial thromboxane A2 in the vasoconstrictor response induced by 15-E2t-isoprostane in isolated human umbilical vein.
    Daray FM; Colombo JR; Kibrik JR; Errasti AE; Pelorosso FG; Nowak W; Cracowski JL; Rothlin RP
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Aug; 373(5):367-75. PubMed ID: 16738877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diversity of endothelium-derived vasocontracting factors--arachidonic acid metabolites.
    Kurahashi K; Nishihashi T; Trandafir CC; Wang AM; Murakami S; Ji X
    Acta Pharmacol Sin; 2003 Nov; 24(11):1065-9. PubMed ID: 14627486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms underlying uridine adenosine tetraphosphate-induced vascular contraction in mouse aorta: Role of thromboxane and purinergic receptors.
    Zhou Z; Sun C; Tilley SL; Mustafa SJ
    Vascul Pharmacol; 2015 Oct; 73():78-85. PubMed ID: 25921923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of BM-573 [N-terbutyl-N'-[2-(4'-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, in a porcine model of acute pulmonary embolism.
    Ghuysen A; Lambermont B; Dogné JM; Kolh P; Tchana-Sato V; Morimont P; Magis D; Hanson J; Segers P; D'Orio V
    J Pharmacol Exp Ther; 2004 Sep; 310(3):964-72. PubMed ID: 15121765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of thromboxane A2 (TXA2) in the early stages of oleic acid-induced lung injury and the preventive effect of ozagrel, a TXA2 synthase inhibitor, in guinea-pigs.
    Ishitsuka Y; Moriuchi H; Hatamoto K; Yang C; Takase J; Golbidi S; Irikura M; Irie T
    J Pharm Pharmacol; 2004 Apr; 56(4):513-20. PubMed ID: 15099446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of thromboxane A2 in the mediation of the contractile effect induced by inhibition of nitric oxide synthesis in isolated rat middle cerebral arteries.
    Benyó Z; Görlach C; Wahl M
    J Cereb Blood Flow Metab; 1998 Jun; 18(6):616-8. PubMed ID: 9626185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of thromboxane A2 synthetase inhibitor, DP-1904 on the action of vasoactive substances in rabbit blood vessel smooth muscle preparations].
    Shimizu K; Kobayashi J; Iwanaga T; Kuratomi Y; Kitamura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 May; 27(5):591-6. PubMed ID: 2615099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline-perfused rabbit lungs.
    Tate RM; Morris HG; Schroeder WR; Repine JE
    J Clin Invest; 1984 Aug; 74(2):608-13. PubMed ID: 6547730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular responsiveness to dimethylaminoethyl methacrylate and its degradation products.
    Abebe W; Maddux WF; Schuster GS; Lewis JB
    J Biomed Mater Res A; 2003 Jul; 66(1):155-61. PubMed ID: 12833442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thromboxane rather than platelet activating factor mediates pulmonary vasoconstriction after antigen challenge in rabbits.
    Enzan K; Kurosawa S; Yoshioka N; Inaba H
    Shock; 1996 Sep; 6(3):183-7. PubMed ID: 8885083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 1-[3-(4-benzhydryl-1-piperazinyl)propyl]-3- (1H-imidazol-1-ylmethyl)-1H-indole-6-carboxylic acid with thromboxane A2 synthetase inhibitory and H1-blocking activities on anaphylactic bronchospasm.
    Nakamura S; Shirahase H; Kanda M; Wada K; Kamiya S; Matsui H; Kurahashi K
    Arzneimittelforschung; 1996 Nov; 46(11):1067-71. PubMed ID: 8955866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
    Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
    Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.